Thorne HealthTech, Inc. (NASDAQ: THRN) Stock Competitors & Peer Comparison
See THRN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for THRN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| THRN | $10.19 | -0.10% | 550.6M | 26.13 | $0.39 | N/A |
| JBS | $13.75 | +0.66% | 30.5B | 8.39 | $1.64 | +7.29% |
| KHC | $25.68 | +3.46% | 30.5B | 10.61 | $2.42 | +6.20% |
| GIS | $39.99 | +5.02% | 21.3B | 11.27 | $3.55 | +6.11% |
| MKC | $56.48 | +2.17% | 15.2B | 17.82 | $3.17 | +3.35% |
| MKC-V | $56.05 | +1.06% | 15.1B | 17.75 | $3.16 | +3.36% |
| HRL | $24.41 | +0.31% | 13.4B | 17.32 | $1.41 | +4.77% |
| SJM | $122.84 | +3.66% | 13.1B | 13.42 | $9.15 | +3.61% |
| MICC | $19.41 | +2.27% | 11.9B | 6.81 | $2.85 | N/A |
| DAR | $66.94 | -2.05% | 10.6B | 39.85 | $1.68 | N/A |
Stock Comparison
Jbs N.V. (NYSE: JBS)
THRN vs JBS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, JBS has a market cap of 30.5B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while JBS trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas JBS's P/E ratio is 8.39. In terms of profitability, THRN's ROE is +0.12%, compared to JBS's ROE of +0.18%. Regarding short-term risk, THRN is less volatile compared to JBS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check JBS's competition here
The Kraft Heinz Company (NASDAQ: KHC)
THRN vs KHC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, KHC has a market cap of 30.5B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while KHC trades at $25.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas KHC's P/E ratio is 10.61. In terms of profitability, THRN's ROE is +0.12%, compared to KHC's ROE of -0.08%. Regarding short-term risk, THRN is less volatile compared to KHC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check KHC's competition here
General Mills, Inc. (NYSE: GIS)
THRN vs GIS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, GIS has a market cap of 21.3B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while GIS trades at $39.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas GIS's P/E ratio is 11.27. In terms of profitability, THRN's ROE is +0.12%, compared to GIS's ROE of -0.01%. Regarding short-term risk, THRN is less volatile compared to GIS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check GIS's competition here
McCormick & Company, Incorporated (NYSE: MKC)
THRN vs MKC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MKC has a market cap of 15.2B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MKC trades at $56.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MKC's P/E ratio is 17.82. In terms of profitability, THRN's ROE is +0.12%, compared to MKC's ROE of +0.26%. Regarding short-term risk, THRN is less volatile compared to MKC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MKC's competition here
McCormick & Company, Incorporated (NYSE: MKC-V)
THRN vs MKC-V Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MKC-V has a market cap of 15.1B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MKC-V trades at $56.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MKC-V's P/E ratio is 17.75. In terms of profitability, THRN's ROE is +0.12%, compared to MKC-V's ROE of +0.26%. Regarding short-term risk, THRN is less volatile compared to MKC-V. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MKC-V's competition here
Hormel Foods Corporation (NYSE: HRL)
THRN vs HRL Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, HRL has a market cap of 13.4B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while HRL trades at $24.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas HRL's P/E ratio is 17.32. In terms of profitability, THRN's ROE is +0.12%, compared to HRL's ROE of +0.06%. Regarding short-term risk, THRN is less volatile compared to HRL. This indicates lower risk in terms of short-term price fluctuations for THRN.Check HRL's competition here
The J. M. Smucker Company (NYSE: SJM)
THRN vs SJM Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SJM has a market cap of 13.1B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SJM trades at $122.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SJM's P/E ratio is 13.42. In terms of profitability, THRN's ROE is +0.12%, compared to SJM's ROE of -0.02%. Regarding short-term risk, THRN is less volatile compared to SJM. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SJM's competition here
The Magnum Ice Cream Company N.V. (NYSE: MICC)
THRN vs MICC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MICC has a market cap of 11.9B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MICC trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MICC's P/E ratio is 6.81. In terms of profitability, THRN's ROE is +0.12%, compared to MICC's ROE of +0.32%. Regarding short-term risk, THRN is less volatile compared to MICC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MICC's competition here
Darling Ingredients Inc. (NYSE: DAR)
THRN vs DAR Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, DAR has a market cap of 10.6B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while DAR trades at $66.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas DAR's P/E ratio is 39.85. In terms of profitability, THRN's ROE is +0.12%, compared to DAR's ROE of +0.12%. Regarding short-term risk, THRN is less volatile compared to DAR. This indicates lower risk in terms of short-term price fluctuations for THRN.Check DAR's competition here
Smithfield Foods, Inc. (NASDAQ: SFD)
THRN vs SFD Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SFD has a market cap of 8.9B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SFD trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SFD's P/E ratio is 8.45. In terms of profitability, THRN's ROE is +0.12%, compared to SFD's ROE of +0.16%. Regarding short-term risk, THRN is less volatile compared to SFD. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SFD's competition here
Conagra Brands, Inc. (NYSE: CAG)
THRN vs CAG Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, CAG has a market cap of 7.8B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while CAG trades at $16.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas CAG's P/E ratio is 9.54. In terms of profitability, THRN's ROE is +0.12%, compared to CAG's ROE of -0.24%. Regarding short-term risk, THRN is less volatile compared to CAG. This indicates lower risk in terms of short-term price fluctuations for THRN.Check CAG's competition here
Pilgrim's Pride Corporation (NASDAQ: PPC)
THRN vs PPC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, PPC has a market cap of 7.4B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while PPC trades at $31.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas PPC's P/E ratio is 7.09. In terms of profitability, THRN's ROE is +0.12%, compared to PPC's ROE of +0.15%. Regarding short-term risk, THRN is less volatile compared to PPC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check PPC's competition here
Lamb Weston Holdings, Inc. (NYSE: LW)
THRN vs LW Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, LW has a market cap of 7.4B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while LW trades at $53.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas LW's P/E ratio is 17.82. In terms of profitability, THRN's ROE is +0.12%, compared to LW's ROE of +0.16%. Regarding short-term risk, THRN is less volatile compared to LW. This indicates lower risk in terms of short-term price fluctuations for THRN.Check LW's competition here
Campbell Soup Company (NASDAQ: CPB)
THRN vs CPB Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, CPB has a market cap of 7.1B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while CPB trades at $23.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas CPB's P/E ratio is 9.92. In terms of profitability, THRN's ROE is +0.12%, compared to CPB's ROE of +0.15%. Regarding short-term risk, THRN is less volatile compared to CPB. This indicates lower risk in terms of short-term price fluctuations for THRN.Check CPB's competition here
Ingredion Incorporated (NYSE: INGR)
THRN vs INGR Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, INGR has a market cap of 6.8B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while INGR trades at $107.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas INGR's P/E ratio is 10.26. In terms of profitability, THRN's ROE is +0.12%, compared to INGR's ROE of +0.13%. Regarding short-term risk, THRN is less volatile compared to INGR. This indicates lower risk in terms of short-term price fluctuations for THRN.Check INGR's competition here
BRF S.A. (NYSE: BRFS)
THRN vs BRFS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRFS has a market cap of 5.4B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRFS trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRFS's P/E ratio is 8.24. In terms of profitability, THRN's ROE is +0.12%, compared to BRFS's ROE of +0.11%. Regarding short-term risk, THRN is less volatile compared to BRFS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRFS's competition here
Lancaster Colony Corporation (NASDAQ: LANC)
THRN vs LANC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, LANC has a market cap of 4.8B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while LANC trades at $172.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas LANC's P/E ratio is 28.09. In terms of profitability, THRN's ROE is +0.12%, compared to LANC's ROE of +0.17%. Regarding short-term risk, THRN is less volatile compared to LANC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check LANC's competition here
Hostess Brands, Inc. (NASDAQ: TWNK)
THRN vs TWNK Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, TWNK has a market cap of 4.4B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while TWNK trades at $33.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas TWNK's P/E ratio is 26.64. In terms of profitability, THRN's ROE is +0.12%, compared to TWNK's ROE of +0.09%. Regarding short-term risk, THRN is less volatile compared to TWNK. This indicates lower risk in terms of short-term price fluctuations for THRN.Check TWNK's competition here
Hostess Brands, Inc. (NASDAQ: TWNKW)
THRN vs TWNKW Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, TWNKW has a market cap of 4.4B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while TWNKW trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas TWNKW's P/E ratio is 5.15. In terms of profitability, THRN's ROE is +0.12%, compared to TWNKW's ROE of +0.09%. Regarding short-term risk, THRN is less volatile compared to TWNKW. This indicates lower risk in terms of short-term price fluctuations for THRN.Check TWNKW's competition here
Freshpet, Inc. (NASDAQ: FRPT)
THRN vs FRPT Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FRPT has a market cap of 3.7B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FRPT trades at $75.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FRPT's P/E ratio is 48.00. In terms of profitability, THRN's ROE is +0.12%, compared to FRPT's ROE of +0.17%. Regarding short-term risk, THRN is less volatile compared to FRPT. This indicates lower risk in terms of short-term price fluctuations for THRN.Check FRPT's competition here
Post Holdings, Inc. (NYSE: POST)
THRN vs POST Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, POST has a market cap of 3.6B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while POST trades at $78.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas POST's P/E ratio is 9.63. In terms of profitability, THRN's ROE is +0.12%, compared to POST's ROE of +0.09%. Regarding short-term risk, THRN is less volatile compared to POST. This indicates lower risk in terms of short-term price fluctuations for THRN.Check POST's competition here
The Marzetti Company (NASDAQ: MZTI)
THRN vs MZTI Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MZTI has a market cap of 3.2B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MZTI trades at $116.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MZTI's P/E ratio is 17.35. In terms of profitability, THRN's ROE is +0.12%, compared to MZTI's ROE of +0.17%. Regarding short-term risk, THRN is less volatile compared to MZTI. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MZTI's competition here
Central Garden & Pet Company (NASDAQ: CENTA)
THRN vs CENTA Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, CENTA has a market cap of 2.8B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while CENTA trades at $38.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas CENTA's P/E ratio is 13.05. In terms of profitability, THRN's ROE is +0.12%, compared to CENTA's ROE of +0.10%. Regarding short-term risk, THRN is less volatile compared to CENTA. This indicates lower risk in terms of short-term price fluctuations for THRN.Check CENTA's competition here
Sovos Brands, Inc. (NASDAQ: SOVO)
THRN vs SOVO Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SOVO has a market cap of 2.3B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SOVO trades at $22.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SOVO's P/E ratio is 79.24. In terms of profitability, THRN's ROE is +0.12%, compared to SOVO's ROE of +0.06%. Regarding short-term risk, THRN is less volatile compared to SOVO. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SOVO's competition here
WK Kellogg Co (NYSE: KLG)
THRN vs KLG Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, KLG has a market cap of 2B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while KLG trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas KLG's P/E ratio is 67.65. In terms of profitability, THRN's ROE is +0.12%, compared to KLG's ROE of +0.09%. Regarding short-term risk, THRN is more volatile compared to KLG. This indicates higher risk in terms of short-term price fluctuations for THRN.Check KLG's competition here
J&J Snack Foods Corp. (NASDAQ: JJSF)
THRN vs JJSF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, JJSF has a market cap of 1.7B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while JJSF trades at $90.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas JJSF's P/E ratio is 21.25. In terms of profitability, THRN's ROE is +0.12%, compared to JJSF's ROE of +0.05%. Regarding short-term risk, THRN is less volatile compared to JJSF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check JJSF's competition here
Nomad Foods Limited (NYSE: NOMD)
THRN vs NOMD Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, NOMD has a market cap of 1.6B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while NOMD trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas NOMD's P/E ratio is 6.39. In terms of profitability, THRN's ROE is +0.12%, compared to NOMD's ROE of +0.05%. Regarding short-term risk, THRN is less volatile compared to NOMD. This indicates lower risk in terms of short-term price fluctuations for THRN.Check NOMD's competition here
Flowers Foods, Inc. (NYSE: FLO)
THRN vs FLO Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FLO has a market cap of 1.6B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FLO trades at $7.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FLO's P/E ratio is 7.18. In terms of profitability, THRN's ROE is +0.12%, compared to FLO's ROE of +0.05%. Regarding short-term risk, THRN is less volatile compared to FLO. This indicates lower risk in terms of short-term price fluctuations for THRN.Check FLO's competition here
Seneca Foods Corporation (NASDAQ: SENEB)
THRN vs SENEB Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SENEB has a market cap of 1.3B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SENEB trades at $191.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SENEB's P/E ratio is 11.91. In terms of profitability, THRN's ROE is +0.12%, compared to SENEB's ROE of +0.16%. Regarding short-term risk, THRN is more volatile compared to SENEB. This indicates higher risk in terms of short-term price fluctuations for THRN.Check SENEB's competition here
Seneca Foods Corporation (NASDAQ: SENEA)
THRN vs SENEA Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SENEA has a market cap of 1.3B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SENEA trades at $192.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SENEA's P/E ratio is 11.89. In terms of profitability, THRN's ROE is +0.12%, compared to SENEA's ROE of +0.16%. Regarding short-term risk, THRN is less volatile compared to SENEA. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SENEA's competition here
Herbalife Nutrition Ltd. (NYSE: HLF)
THRN vs HLF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, HLF has a market cap of 1.3B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while HLF trades at $12.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas HLF's P/E ratio is 5.94. In terms of profitability, THRN's ROE is +0.12%, compared to HLF's ROE of -0.32%. Regarding short-term risk, THRN is less volatile compared to HLF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check HLF's competition here
Utz Brands, Inc. (NYSE: UTZ)
THRN vs UTZ Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, UTZ has a market cap of 1.3B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while UTZ trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas UTZ's P/E ratio is 17.05. In terms of profitability, THRN's ROE is +0.12%, compared to UTZ's ROE of -0.04%. Regarding short-term risk, THRN is less volatile compared to UTZ. This indicates lower risk in terms of short-term price fluctuations for THRN.Check UTZ's competition here
BellRing Brands, Inc. (NYSE: BRBR)
THRN vs BRBR Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRBR has a market cap of 1.2B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRBR trades at $10.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRBR's P/E ratio is 8.13. In terms of profitability, THRN's ROE is +0.12%, compared to BRBR's ROE of -0.36%. Regarding short-term risk, THRN is less volatile compared to BRBR. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRBR's competition here
TreeHouse Foods, Inc. (NYSE: THS)
THRN vs THS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, THS has a market cap of 1.2B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while THS trades at $24.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas THS's P/E ratio is -5.05. In terms of profitability, THRN's ROE is +0.12%, compared to THS's ROE of -0.21%. Regarding short-term risk, THRN is less volatile compared to THS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check THS's competition here
The Simply Good Foods Company (NASDAQ: SMPL)
THRN vs SMPL Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SMPL has a market cap of 1B. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SMPL trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SMPL's P/E ratio is 6.66. In terms of profitability, THRN's ROE is +0.12%, compared to SMPL's ROE of -0.12%. Regarding short-term risk, THRN is less volatile compared to SMPL. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SMPL's competition here
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS)
THRN vs JBSS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, JBSS has a market cap of 950.4M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while JBSS trades at $81.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas JBSS's P/E ratio is 14.26. In terms of profitability, THRN's ROE is +0.12%, compared to JBSS's ROE of +0.18%. Regarding short-term risk, THRN is less volatile compared to JBSS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check JBSS's competition here
Westrock Coffee Company, LLC (NASDAQ: WEST)
THRN vs WEST Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, WEST has a market cap of 834.1M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while WEST trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas WEST's P/E ratio is -20.36. In terms of profitability, THRN's ROE is +0.12%, compared to WEST's ROE of -0.24%. Regarding short-term risk, THRN is less volatile compared to WEST. This indicates lower risk in terms of short-term price fluctuations for THRN.Check WEST's competition here
SunOpta Inc. (NASDAQ: STKL)
THRN vs STKL Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, STKL has a market cap of 769.4M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while STKL trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas STKL's P/E ratio is 50.00. In terms of profitability, THRN's ROE is +0.12%, compared to STKL's ROE of +0.09%. Regarding short-term risk, THRN is less volatile compared to STKL. This indicates lower risk in terms of short-term price fluctuations for THRN.Check STKL's competition here
Mama's Creations, Inc. (NASDAQ: MAMA)
THRN vs MAMA Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MAMA has a market cap of 766.3M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MAMA trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MAMA's P/E ratio is 103.00. In terms of profitability, THRN's ROE is +0.12%, compared to MAMA's ROE of +0.13%. Regarding short-term risk, THRN is less volatile compared to MAMA. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MAMA's competition here
Once Upon A Farm Pbc (NYSE: OFRM)
THRN vs OFRM Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, OFRM has a market cap of 751.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while OFRM trades at $17.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas OFRM's P/E ratio is -37.27. In terms of profitability, THRN's ROE is +0.12%, compared to OFRM's ROE of -0.92%. Regarding short-term risk, THRN is less volatile compared to OFRM. This indicates lower risk in terms of short-term price fluctuations for THRN.Check OFRM's competition here
Oatly Group AB (NASDAQ: OTLY)
THRN vs OTLY Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, OTLY has a market cap of 431.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while OTLY trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas OTLY's P/E ratio is -2.76. In terms of profitability, THRN's ROE is +0.12%, compared to OTLY's ROE of -31.33%. Regarding short-term risk, THRN is less volatile compared to OTLY. This indicates lower risk in terms of short-term price fluctuations for THRN.Check OTLY's competition here
Lifeway Foods, Inc. (NASDAQ: LWAY)
THRN vs LWAY Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, LWAY has a market cap of 382.7M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while LWAY trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas LWAY's P/E ratio is 25.81. In terms of profitability, THRN's ROE is +0.12%, compared to LWAY's ROE of +0.13%. Regarding short-term risk, THRN is less volatile compared to LWAY. This indicates lower risk in terms of short-term price fluctuations for THRN.Check LWAY's competition here
B&G Foods, Inc. (NYSE: BGS)
THRN vs BGS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BGS has a market cap of 287.7M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BGS trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BGS's P/E ratio is 6.45. In terms of profitability, THRN's ROE is +0.12%, compared to BGS's ROE of -0.16%. Regarding short-term risk, THRN is less volatile compared to BGS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BGS's competition here
BRC Inc. (NYSE: BRCC)
THRN vs BRCC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRCC has a market cap of 258.7M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRCC trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRCC's P/E ratio is -21.90. In terms of profitability, THRN's ROE is +0.12%, compared to BRCC's ROE of -0.08%. Regarding short-term risk, THRN is less volatile compared to BRCC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRCC's competition here
Nature's Sunshine Products, Inc. (NASDAQ: NATR)
THRN vs NATR Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, NATR has a market cap of 256M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while NATR trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas NATR's P/E ratio is 11.11. In terms of profitability, THRN's ROE is +0.12%, compared to NATR's ROE of +0.11%. Regarding short-term risk, THRN is less volatile compared to NATR. This indicates lower risk in terms of short-term price fluctuations for THRN.Check NATR's competition here
Beyond Meat, Inc. (NASDAQ: BYND)
THRN vs BYND Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BYND has a market cap of 241.9M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BYND trades at $14.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BYND's P/E ratio is -16.96. In terms of profitability, THRN's ROE is +0.12%, compared to BYND's ROE of -1.55%. Regarding short-term risk, THRN is less volatile compared to BYND. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BYND's competition here
Whole Earth Brands, Inc. (NASDAQ: FREE)
THRN vs FREE Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FREE has a market cap of 211.6M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FREE trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FREE's P/E ratio is -8.54. In terms of profitability, THRN's ROE is +0.12%, compared to FREE's ROE of -0.14%. Regarding short-term risk, THRN is less volatile compared to FREE. This indicates lower risk in terms of short-term price fluctuations for THRN.Check FREE's competition here
Westrock Coffee Company, LLC (NASDAQ: WESTW)
THRN vs WESTW Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, WESTW has a market cap of 168.4M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while WESTW trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas WESTW's P/E ratio is N/A. In terms of profitability, THRN's ROE is +0.12%, compared to WESTW's ROE of -0.24%. Regarding short-term risk, THRN is less volatile compared to WESTW. This indicates lower risk in terms of short-term price fluctuations for THRN.Check WESTW's competition here
MamaMancini's Holdings, Inc. (NASDAQ: MMMB)
THRN vs MMMB Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MMMB has a market cap of 136.8M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MMMB trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MMMB's P/E ratio is 41.67. In terms of profitability, THRN's ROE is +0.12%, compared to MMMB's ROE of +0.13%. Regarding short-term risk, THRN is less volatile compared to MMMB. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MMMB's competition here
China Xiangtai Food Co., Ltd. (NASDAQ: PLIN)
THRN vs PLIN Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, PLIN has a market cap of 115.6M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while PLIN trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas PLIN's P/E ratio is -0.83. In terms of profitability, THRN's ROE is +0.12%, compared to PLIN's ROE of -4.43%. Regarding short-term risk, THRN is less volatile compared to PLIN. This indicates lower risk in terms of short-term price fluctuations for THRN.Check PLIN's competition here
FitLife Brands, Inc. (NASDAQ: FTLF)
THRN vs FTLF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FTLF has a market cap of 96.1M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FTLF trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FTLF's P/E ratio is 15.99. In terms of profitability, THRN's ROE is +0.12%, compared to FTLF's ROE of +0.14%. Regarding short-term risk, THRN is less volatile compared to FTLF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check FTLF's competition here
LifeVantage Corporation (NASDAQ: LFVN)
THRN vs LFVN Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, LFVN has a market cap of 82M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while LFVN trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas LFVN's P/E ratio is 10.48. In terms of profitability, THRN's ROE is +0.12%, compared to LFVN's ROE of +0.18%. Regarding short-term risk, THRN is less volatile compared to LFVN. This indicates lower risk in terms of short-term price fluctuations for THRN.Check LFVN's competition here
Wing Yip Food Holdings Group Limited American Depositary Shares (NASDAQ: WYHG)
THRN vs WYHG Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, WYHG has a market cap of 59.9M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while WYHG trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas WYHG's P/E ratio is 125.26. In terms of profitability, THRN's ROE is +0.12%, compared to WYHG's ROE of +0.03%. Regarding short-term risk, THRN is less volatile compared to WYHG. This indicates lower risk in terms of short-term price fluctuations for THRN.Check WYHG's competition here
MeaTech 3D Ltd. (NASDAQ: MITC)
THRN vs MITC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MITC has a market cap of 57.5M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MITC trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MITC's P/E ratio is -2.15. In terms of profitability, THRN's ROE is +0.12%, compared to MITC's ROE of -2.21%. Regarding short-term risk, THRN is less volatile compared to MITC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MITC's competition here
BranchOut Food Inc. (NASDAQ: BOF)
THRN vs BOF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BOF has a market cap of 56.7M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BOF trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BOF's P/E ratio is -6.27. In terms of profitability, THRN's ROE is +0.12%, compared to BOF's ROE of -1.54%. Regarding short-term risk, THRN is less volatile compared to BOF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BOF's competition here
The Hain Celestial Group, Inc. (NASDAQ: HAIN)
THRN vs HAIN Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, HAIN has a market cap of 56.6M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while HAIN trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas HAIN's P/E ratio is -0.20. In terms of profitability, THRN's ROE is +0.12%, compared to HAIN's ROE of -1.41%. Regarding short-term risk, THRN is less volatile compared to HAIN. This indicates lower risk in terms of short-term price fluctuations for THRN.Check HAIN's competition here
Bridgford Foods Corporation (NASDAQ: BRID)
THRN vs BRID Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRID has a market cap of 55.5M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRID trades at $6.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRID's P/E ratio is -3.94. In terms of profitability, THRN's ROE is +0.12%, compared to BRID's ROE of -0.12%. Regarding short-term risk, THRN is less volatile compared to BRID. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRID's competition here
Laird Superfood, Inc. (AMEX: LSF)
THRN vs LSF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, LSF has a market cap of 48.1M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while LSF trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas LSF's P/E ratio is -10.66. In terms of profitability, THRN's ROE is +0.12%, compared to LSF's ROE of -0.11%. Regarding short-term risk, THRN is less volatile compared to LSF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check LSF's competition here
Calyxt, Inc. (NASDAQ: CLXT)
THRN vs CLXT Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, CLXT has a market cap of 31.3M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while CLXT trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas CLXT's P/E ratio is -1.64. In terms of profitability, THRN's ROE is +0.12%, compared to CLXT's ROE of -3.23%. Regarding short-term risk, THRN is less volatile compared to CLXT. This indicates lower risk in terms of short-term price fluctuations for THRN.Check CLXT's competition here
Happiness Development Group Limited (NASDAQ: HAPP)
THRN vs HAPP Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, HAPP has a market cap of 31.3M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while HAPP trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas HAPP's P/E ratio is -0.18. In terms of profitability, THRN's ROE is +0.12%, compared to HAPP's ROE of -0.62%. Regarding short-term risk, THRN is less volatile compared to HAPP. This indicates lower risk in terms of short-term price fluctuations for THRN.Check HAPP's competition here
Farmer Bros. Co. (NASDAQ: FARM)
THRN vs FARM Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FARM has a market cap of 28.1M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FARM trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FARM's P/E ratio is -1.49. In terms of profitability, THRN's ROE is +0.12%, compared to FARM's ROE of -0.48%. Regarding short-term risk, THRN is more volatile compared to FARM. This indicates higher risk in terms of short-term price fluctuations for THRN.Check FARM's competition here
YanGuFang International Group Co., Ltd. (NASDAQ: YGF)
THRN vs YGF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, YGF has a market cap of 23.5M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while YGF trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas YGF's P/E ratio is 5.24. In terms of profitability, THRN's ROE is +0.12%, compared to YGF's ROE of +0.37%. Regarding short-term risk, THRN is more volatile compared to YGF. This indicates higher risk in terms of short-term price fluctuations for THRN.Check YGF's competition here
Marwynn Holdings, Inc. Common stock (NASDAQ: MWYN)
THRN vs MWYN Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MWYN has a market cap of 21.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MWYN trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MWYN's P/E ratio is -35.00. In terms of profitability, THRN's ROE is +0.12%, compared to MWYN's ROE of -1.57%. Regarding short-term risk, THRN is less volatile compared to MWYN. This indicates lower risk in terms of short-term price fluctuations for THRN.Check MWYN's competition here
Borealis Foods Inc. (NASDAQ: BRLSW)
THRN vs BRLSW Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRLSW has a market cap of 21.1M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRLSW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRLSW's P/E ratio is N/A. In terms of profitability, THRN's ROE is +0.12%, compared to BRLSW's ROE of +1.14%. Regarding short-term risk, THRN is less volatile compared to BRLSW. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRLSW's competition here
Coffee Holding Co., Inc. (NASDAQ: JVA)
THRN vs JVA Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, JVA has a market cap of 20.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while JVA trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas JVA's P/E ratio is 12.61. In terms of profitability, THRN's ROE is +0.12%, compared to JVA's ROE of +0.05%. Regarding short-term risk, THRN is less volatile compared to JVA. This indicates lower risk in terms of short-term price fluctuations for THRN.Check JVA's competition here
Borealis Foods Inc. (NASDAQ: BRLS)
THRN vs BRLS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRLS has a market cap of 18.6M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRLS trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRLS's P/E ratio is -1.04. In terms of profitability, THRN's ROE is +0.12%, compared to BRLS's ROE of +1.14%. Regarding short-term risk, THRN is less volatile compared to BRLS. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRLS's competition here
DDC Enterprise Limited (AMEX: DDC)
THRN vs DDC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, DDC has a market cap of 13.8M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while DDC trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas DDC's P/E ratio is -0.02. In terms of profitability, THRN's ROE is +0.12%, compared to DDC's ROE of -1.31%. Regarding short-term risk, THRN is less volatile compared to DDC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check DDC's competition here
Natural Alternatives International, Inc. (NASDAQ: NAII)
THRN vs NAII Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, NAII has a market cap of 13.3M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while NAII trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas NAII's P/E ratio is -1.56. In terms of profitability, THRN's ROE is +0.12%, compared to NAII's ROE of -0.21%. Regarding short-term risk, THRN is less volatile compared to NAII. This indicates lower risk in terms of short-term price fluctuations for THRN.Check NAII's competition here
Tattooed Chef, Inc. (NASDAQ: TTCF)
THRN vs TTCF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, TTCF has a market cap of 13.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while TTCF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas TTCF's P/E ratio is -0.12. In terms of profitability, THRN's ROE is +0.12%, compared to TTCF's ROE of -0.93%. Regarding short-term risk, THRN is less volatile compared to TTCF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check TTCF's competition here
Australian Oilseeds Holdings Limited Ordinary Shares (NASDAQ: COOT)
THRN vs COOT Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, COOT has a market cap of 12.9M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while COOT trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas COOT's P/E ratio is -43.00. In terms of profitability, THRN's ROE is +0.12%, compared to COOT's ROE of -0.27%. Regarding short-term risk, THRN is less volatile compared to COOT. This indicates lower risk in terms of short-term price fluctuations for THRN.Check COOT's competition here
TDH Holdings, Inc. (NASDAQ: PETZ)
THRN vs PETZ Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, PETZ has a market cap of 12.3M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while PETZ trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas PETZ's P/E ratio is 16.04. In terms of profitability, THRN's ROE is +0.12%, compared to PETZ's ROE of +0.06%. Regarding short-term risk, THRN is less volatile compared to PETZ. This indicates lower risk in terms of short-term price fluctuations for THRN.Check PETZ's competition here
NuZee, Inc. (NASDAQ: NUZE)
THRN vs NUZE Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, NUZE has a market cap of 6.9M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while NUZE trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas NUZE's P/E ratio is -0.10. In terms of profitability, THRN's ROE is +0.12%, compared to NUZE's ROE of -0.94%. Regarding short-term risk, THRN is less volatile compared to NUZE. This indicates lower risk in terms of short-term price fluctuations for THRN.Check NUZE's competition here
Better Choice Company Inc. (AMEX: BTTR)
THRN vs BTTR Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BTTR has a market cap of 5.1M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BTTR trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BTTR's P/E ratio is -21.20. In terms of profitability, THRN's ROE is +0.12%, compared to BTTR's ROE of -0.64%. Regarding short-term risk, THRN is less volatile compared to BTTR. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BTTR's competition here
Farmmi, Inc. (NASDAQ: FAMI)
THRN vs FAMI Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FAMI has a market cap of 3.9M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FAMI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FAMI's P/E ratio is 0.19. In terms of profitability, THRN's ROE is +0.12%, compared to FAMI's ROE of -0.37%. Regarding short-term risk, THRN is less volatile compared to FAMI. This indicates lower risk in terms of short-term price fluctuations for THRN.Check FAMI's competition here
Nocera, Inc. (NASDAQ: NCRA)
THRN vs NCRA Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, NCRA has a market cap of 3.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while NCRA trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas NCRA's P/E ratio is -0.25. In terms of profitability, THRN's ROE is +0.12%, compared to NCRA's ROE of -1.47%. Regarding short-term risk, THRN is less volatile compared to NCRA. This indicates lower risk in terms of short-term price fluctuations for THRN.Check NCRA's competition here
Whole Earth Brands Inc (NASDAQ: FREEW)
THRN vs FREEW Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, FREEW has a market cap of 2.8M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while FREEW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas FREEW's P/E ratio is N/A. In terms of profitability, THRN's ROE is +0.12%, compared to FREEW's ROE of -0.14%. Regarding short-term risk, THRN is less volatile compared to FREEW. This indicates lower risk in terms of short-term price fluctuations for THRN.Check FREEW's competition here
Agape ATP Corporation (NASDAQ: ATPC)
THRN vs ATPC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, ATPC has a market cap of 2.5M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while ATPC trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas ATPC's P/E ratio is 0.26. In terms of profitability, THRN's ROE is +0.12%, compared to ATPC's ROE of -0.05%. Regarding short-term risk, THRN is less volatile compared to ATPC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check ATPC's competition here
Steakholder Foods Ltd. (NASDAQ: STKH)
THRN vs STKH Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, STKH has a market cap of 2.4M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while STKH trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas STKH's P/E ratio is -1.83. In terms of profitability, THRN's ROE is +0.12%, compared to STKH's ROE of -0.90%. Regarding short-term risk, THRN is less volatile compared to STKH. This indicates lower risk in terms of short-term price fluctuations for THRN.Check STKH's competition here
ORIENTAL RISE HOLDINGS Ltd (NASDAQ: ORIS)
THRN vs ORIS Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, ORIS has a market cap of 2.3M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while ORIS trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas ORIS's P/E ratio is 1.31. In terms of profitability, THRN's ROE is +0.12%, compared to ORIS's ROE of +0.01%. Regarding short-term risk, THRN is more volatile compared to ORIS. This indicates higher risk in terms of short-term price fluctuations for THRN.Check ORIS's competition here
The Real Good Food Company, Inc. (NASDAQ: RGF)
THRN vs RGF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, RGF has a market cap of 2.2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while RGF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas RGF's P/E ratio is -0.05. In terms of profitability, THRN's ROE is +0.12%, compared to RGF's ROE of -0.29%. Regarding short-term risk, THRN is more volatile compared to RGF. This indicates higher risk in terms of short-term price fluctuations for THRN.Check RGF's competition here
CIMG Inc. (NASDAQ: IMG)
THRN vs IMG Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, IMG has a market cap of 2M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while IMG trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas IMG's P/E ratio is -0.17. In terms of profitability, THRN's ROE is +0.12%, compared to IMG's ROE of -0.93%. Regarding short-term risk, THRN is more volatile compared to IMG. This indicates higher risk in terms of short-term price fluctuations for THRN.Check IMG's competition here
Above Food Ingredients Inc. (NASDAQ: ABVE)
THRN vs ABVE Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, ABVE has a market cap of 1.5M. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while ABVE trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas ABVE's P/E ratio is -0.02. In terms of profitability, THRN's ROE is +0.12%, compared to ABVE's ROE of +6.22%. Regarding short-term risk, THRN is less volatile compared to ABVE. This indicates lower risk in terms of short-term price fluctuations for THRN.Check ABVE's competition here
Stryve Foods, Inc. (NASDAQ: SNAXW)
THRN vs SNAXW Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SNAXW has a market cap of 22.5K. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SNAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SNAXW's P/E ratio is -0.04. In terms of profitability, THRN's ROE is +0.12%, compared to SNAXW's ROE of -2.11%. Regarding short-term risk, THRN is less volatile compared to SNAXW. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SNAXW's competition here
DAVIDsTEA Inc. (NASDAQ: DTEA)
THRN vs DTEA Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, DTEA has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while DTEA trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas DTEA's P/E ratio is -1.44. In terms of profitability, THRN's ROE is +0.12%, compared to DTEA's ROE of +9.18%. Regarding short-term risk, THRN is less volatile compared to DTEA. This indicates lower risk in terms of short-term price fluctuations for THRN.Check DTEA's competition here
Sanderson Farms, Inc. (NASDAQ: SAFM)
THRN vs SAFM Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, SAFM has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while SAFM trades at $204.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas SAFM's P/E ratio is 5.28. In terms of profitability, THRN's ROE is +0.12%, compared to SAFM's ROE of +0.28%. Regarding short-term risk, THRN is less volatile compared to SAFM. This indicates lower risk in terms of short-term price fluctuations for THRN.Check SAFM's competition here
The Very Good Food Company Inc. (NASDAQ: VGFC)
THRN vs VGFC Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, VGFC has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while VGFC trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas VGFC's P/E ratio is N/A. In terms of profitability, THRN's ROE is +0.12%, compared to VGFC's ROE of -1.70%. Regarding short-term risk, THRN is less volatile compared to VGFC. This indicates lower risk in terms of short-term price fluctuations for THRN.Check VGFC's competition here
Pinnacle Foods Inc. (NYSE: PF)
THRN vs PF Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, PF has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while PF trades at $66.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas PF's P/E ratio is 13.22. In terms of profitability, THRN's ROE is +0.12%, compared to PF's ROE of +0.25%. Regarding short-term risk, THRN is less volatile compared to PF. This indicates lower risk in terms of short-term price fluctuations for THRN.Check PF's competition here
Snyder's-Lance, Inc. (NASDAQ: LNCE)
THRN vs LNCE Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, LNCE has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while LNCE trades at $49.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas LNCE's P/E ratio is N/A. In terms of profitability, THRN's ROE is +0.12%, compared to LNCE's ROE of +0.08%. Regarding short-term risk, THRN is more volatile compared to LNCE. This indicates higher risk in terms of short-term price fluctuations for THRN.Check LNCE's competition here
Mead Johnson Nutrition Co. (NYSE: MJN)
THRN vs MJN Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, MJN has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while MJN trades at $89.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas MJN's P/E ratio is N/A. In terms of profitability, THRN's ROE is +0.12%, compared to MJN's ROE of -0.95%. Regarding short-term risk, THRN is more volatile compared to MJN. This indicates higher risk in terms of short-term price fluctuations for THRN.Check MJN's competition here
Burcon NutraScience Corporation (NASDAQ: BRCN)
THRN vs BRCN Comparison August 2026
Thorne HealthTech, Inc. (NASDAQ: THRN) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THRN stands at 550.6M. In comparison, BRCN has a market cap of 0. Regarding current trading prices, THRN is priced at $10.19 on the NASDAQ, while BRCN trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THRN currently has a P/E ratio of 26.13, whereas BRCN's P/E ratio is -6.67. In terms of profitability, THRN's ROE is +0.12%, compared to BRCN's ROE of N/A. Regarding short-term risk, THRN is less volatile compared to BRCN. This indicates lower risk in terms of short-term price fluctuations for THRN.Check BRCN's competition here